Additionally, the expression levels of common immune checkpoint genes exhibited significant differences between the groups, with an overall trend of higher expression in the low-risk group, reflecting its more robust immune environment ( Fig. 5C ).
← all excerpts
Comprehensive analysis of a palmitoylation-related prognostic signature in colorectal cancer: Implications for immune therapy and personalized treatment.
1
—
—